Phyllis K. Bellin
Finanzdirektor/CFO bei Galimedix Therapeutics, Inc. (Maryland)
Profil
Phyllis K.
Bellin is currently the Chief Financial Officer & Director at Galimedix Therapeutics, Inc. She previously worked as a Corporate Lending Officer at the University of Medicine & Dentistry of New Jersey and as Secretary, Treasurer & VP-Administration at Aevi Genomic Medicine, Inc. She holds an MBA degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Phyllis K. Bellin
| Unternehmen | Position | Beginn |
|---|---|---|
Galimedix Therapeutics, Inc. (Maryland)
 Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Phyllis K. Bellin
| Unternehmen | Position | Ende |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
| AEVI GENOMIC MEDICINE, INC. | Finanzdirektor/CFO | 16.09.2013 |
Ausbildung von Phyllis K. Bellin
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Health Services |
